FDA Approves TALVEY™ (talquetamab-tgvs) for Heavily Pre-Treated Multiple Myeloma (https://www.myeloma.org/news-events/multiple-myeloma-news/fda-approves-talveytm-talquetamab-tgvs-heavily-pre-treated-multiple-myeloma)